Effect of Metronidazole in Infants with Bowel Habit Change: Irrelative to the Clostridium difficile Colonization
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Clinical symptoms associated with Clostridium difficile infection (CDI) can vary widely. Carrier state without apparent symptoms is relatively common during infancy. The objective of this study was to determine the association of C. difficile colonization with bowel habit change and the effect of C. difficile colonization treatment on restoration of normal bowel habit.Methods: Between 2006 and 2014, infants at 1 to 12 months of age with diarrhea for more than 2 weeks who did not improve with conservative care were recruited from Gachon University Gil Medical Center. Infants who were followed up for at least 7 days were included. The presence or absence of C. difficile colonization, effect of metronida-zole, and other medical records were reviewed. To determine the association between CDI and bowel habit change, logistic regression analysis was used.Results: Of a total of 126 infants, 74 (58.7%) were male patients. Of the 126 patients, 27 (21.4%) had C. difficilecolonization. Significant (p＜0.05) risk factors for C. difficile colonization included artificial milk feeding (odds ratio [OR], 4.310; 95% confidence interval [CI], 1.564-11.878), prior rotavirus vaccination (OR, 4.322; 95% CI, 1.018-18.349), and antibiotic use (OR, 4.798; 95% CI, 1.430-16.101). There was improvement in bowel habit after metronidazole therapy (OR, 0.34; 95% CI, 0.15-0.79; p＜0.05), regardless of the presence or absence of C. difficilecolonization,Conclusion: There was no significant correlation between bowel habit change and C. difficile colonization during infancy. However, metronidazole can be used as an optional method to manage functional gastrointestinal disorders.
Abstract
Purpose: Clinical symptoms associated with Clostridium difficile infection (CDI) can vary widely. Carrier state without apparent symptoms is relatively common during infancy. The objective of this study was to determine the association of C. difficile colonization with bowel habit change and the effect of C. difficile colonization treatment on restoration of normal bowel habit.Methods: Between 2006 and 2014, infants at 1 to 12 months of age with diarrhea for more than 2 weeks who did not improve with conservative care were recruited from Gachon University Gil Medical Center. Infants who were followed up for at least 7 days were included. The presence or absence of C. difficile colonization, effect of metronida-zole, and other medical records were reviewed. To determine the association between CDI and bowel habit change, logistic regression analysis was used.Results: Of a total of 126 infants, 74 (58.7%) were male patients. Of the 126 patients, 27 (21.4%) had C. difficilecolonization. Significant (p＜0.05) risk factors for C. difficile colonization included artificial milk feeding (odds ratio [OR], 4.310; 95% confidence interval [CI], 1.564-11.878), prior rotavirus vaccination (OR, 4.322; 95% CI, 1.018-18.349), and antibiotic use (OR, 4.798; 95% CI, 1.430-16.101). There was improvement in bowel habit after metronidazole therapy (OR, 0.34; 95% CI, 0.15-0.79; p＜0.05), regardless of the presence or absence of C. difficilecolonization,Conclusion: There was no significant correlation between bowel habit change and C. difficile colonization during infancy. However, metronidazole can be used as an optional method to manage functional gastrointestinal disorders.
참고문헌 (34)
- Pezzella V, "Investigation of chronic diarrhoea in infancy", Early Hum Dev, 89, pp.893~897 (2013)
- Langley JM, "The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children", Infect Control Hosp Epidemiol, 23, pp.660~664 (2002)
- Kim J, "Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006", Pediatrics, 122, pp.1266~1270 (2008)
- Sammons JS, "Clostridium difficile infection in children", JAMA Pediatr, 167, pp.567~573 (2013)
- Leffler DA, "Clostridium difficile infection", N Engl J Med, 372, pp.1539~1548 (2015)
- Rousseau C, "Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains", Clin Infect Dis, 55, pp.1209~1215 (2012)
- Kelly CP, "Clostridium difficile colitis", N Engl J Med, 330, pp.257~262 (1994)
- Schutze GE, "Clostridium difficile infection in infants and children", Pediatrics, 131, pp.196~200 (2013)
- Sandora TJ, "Epidemiology and risk factors for Clostridium difficile infection in children", Pediatr Infect Dis J, 30, pp.580~584 (2011)
- Rasquin-Weber A, "Childhood functional gastrointestinal disorders", Gut, 45(Suppl 2), pp.II60~II68 (1999)
- Almeida R, "Recurrent Clostridium difficile infection and the microbiome", J Gastroenterol, 51, pp.1~10 (2016)
- Rineh A, "Clostridium difficile infection: molecular pathogenesis and novel therapeutics", Expert Rev Anti Infect Ther, 12, pp.131~150 (2014)
- Rousseau C, "Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition", J Clin Microbiol, 49, pp.858~865 (2011)
- Benson L, "Changing epidemiology of Clostridium difficile-associated disease in children", Infect Control Hosp Epidemiol, 28, pp.1233~1235 (2007)
- Cohen MB, "Clostridium difficile infections: emerging epidemiology and new treatments", J Pediatr Gastroenterol Nutr, 48(Suppl 2), pp.S63~S65 (2009)
- Owens RC Jr, "Antimicrobial-associated risk factors for Clostridium difficile infection", Clin Infect Dis, 46(Suppl 1), pp.S19~S31 (2008)
- Benno Y, "The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants", Microbiol Immunol, 28, pp.975~986 (1984)
- Rolfe RD, "Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding", J Med Microbiol, 42, pp.10~19 (1995)
- Sekirov I, "Gut microbiota in health and disease", Physiol Rev, 90, pp.859~904 (2010)
- Ang L, "The establishment of the infant intestinal microbiome is not affected by rotavirus vaccination", Sci Rep, 4, pp.7417~ (2014)
- Leonard J, "Systematic review of the risk of enteric infection in patients taking acid suppression", Am J Gastroenterol, 102, pp.2047~2056 (2007)
- Mezoff EA, "Acid suppression and the risk of Clostridium difficile infection", J Pediatr, 163, pp.627~630 (2013)
- Dial S, "Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease", JAMA, 294, pp.2989~2995 (2005)
- Evans CT, "Prevention of Clostridium difficile infection with probiotics", Clin Infect Dis, 60(Suppl 2), pp.S122~S128 (2015)
- Johnston BC, "Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis", Ann Intern Med, 157, pp.878~888 (2012)
- Allen SJ, "Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial", Lancet, 382, pp.1249~1257 (2013)
- 나재윤, "Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective", Pediatric Gastroenterology, Hepatology & Nutrition, 17(4), pp.232~238 (2014), 대한소아소화기영양학회
- Pant C, "Clostridium difficile infection in children: a comprehensive review", Curr Med Res Opin, 29, pp.967~984 (2013)
- Loo VG, "Host and pathogen factors for Clostridium difficile infection and colonization", N Engl J Med, 365, pp.1693~1703 (2011)
- Hung YP, "Clinical impact of Clostridium difficile colonization", J Microbiol Immunol Infect, 48, pp.241~248 (2015)
- Halvorson HA, "Postinfectious irritable bowel syndrome--a meta-analysis", Am J Gastroenterol, 101, pp.1894~1899 (2006)
- Thabane M, "Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome", Aliment Pharmacol Ther, 26, pp.535~544 (2007)
- Anthony Lembo, "Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome", Gastroenterology, 151(6), pp.1113~1121 (2016), Elsevier BV[DOI]
- Pérez-Cobas AE, "Structural and functional changes in the gut microbiota associated to Clostridium difficile infection", Front Microbiol, 5, pp.335~ (2014)